symbol,statement_type,period_end,line_item,value
NURECA.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
NURECA.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.370067
NURECA.NS,income,2025-03-31 00:00:00,Normalized EBITDA,48950000.0
NURECA.NS,income,2025-03-31 00:00:00,Total Unusual Items,
NURECA.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
NURECA.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,8460000.0
NURECA.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,23380000.0
NURECA.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,680120000.0
NURECA.NS,income,2025-03-31 00:00:00,EBITDA,48950000.0
NURECA.NS,income,2025-03-31 00:00:00,EBIT,25570000.0
NURECA.NS,income,2025-03-31 00:00:00,Net Interest Income,-12140000.0
NURECA.NS,income,2025-03-31 00:00:00,Interest Expense,12140000.0
NURECA.NS,income,2025-03-31 00:00:00,Interest Income,
NURECA.NS,income,2025-03-31 00:00:00,Normalized Income,8460000.0
NURECA.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,8460000.0
NURECA.NS,income,2025-03-31 00:00:00,Total Expenses,1195390000.0
NURECA.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
NURECA.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
NURECA.NS,income,2025-03-31 00:00:00,Basic Average Shares,
NURECA.NS,income,2025-03-31 00:00:00,Diluted EPS,
NURECA.NS,income,2025-03-31 00:00:00,Basic EPS,
NURECA.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,8460000.0
NURECA.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,8460000.0
NURECA.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
NURECA.NS,income,2025-03-31 00:00:00,Net Income,8460000.0
NURECA.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,8460000.0
NURECA.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,8460000.0
NURECA.NS,income,2025-03-31 00:00:00,Tax Provision,4970000.0
NURECA.NS,income,2025-03-31 00:00:00,Pretax Income,13430000.0
NURECA.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,124350000.0
NURECA.NS,income,2025-03-31 00:00:00,Special Income Charges,
NURECA.NS,income,2025-03-31 00:00:00,Write Off,
NURECA.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-12140000.0
NURECA.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
NURECA.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,12140000.0
NURECA.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
NURECA.NS,income,2025-03-31 00:00:00,Operating Income,-98780000.0
NURECA.NS,income,2025-03-31 00:00:00,Operating Expense,515270000.0
NURECA.NS,income,2025-03-31 00:00:00,Other Operating Expenses,338820000.0
NURECA.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,23380000.0
NURECA.NS,income,2025-03-31 00:00:00,Amortization,
NURECA.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,23380000.0
NURECA.NS,income,2025-03-31 00:00:00,Selling General And Administration,
NURECA.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
NURECA.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
NURECA.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
NURECA.NS,income,2025-03-31 00:00:00,Gross Profit,416490000.0
NURECA.NS,income,2025-03-31 00:00:00,Cost Of Revenue,680120000.0
NURECA.NS,income,2025-03-31 00:00:00,Total Revenue,1096610000.0
NURECA.NS,income,2025-03-31 00:00:00,Operating Revenue,1096610000.0
NURECA.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
NURECA.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.294811
NURECA.NS,income,2024-03-31 00:00:00,Normalized EBITDA,3070000.0
NURECA.NS,income,2024-03-31 00:00:00,Total Unusual Items,53830000.0
NURECA.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,53830000.0
NURECA.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-17940000.0
NURECA.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,23620000.0
NURECA.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,606150000.0
NURECA.NS,income,2024-03-31 00:00:00,EBITDA,3070000.0
NURECA.NS,income,2024-03-31 00:00:00,EBIT,-20550000.0
NURECA.NS,income,2024-03-31 00:00:00,Net Interest Income,-4890000.0
NURECA.NS,income,2024-03-31 00:00:00,Interest Expense,4890000.0
NURECA.NS,income,2024-03-31 00:00:00,Interest Income,38920000.0
NURECA.NS,income,2024-03-31 00:00:00,Normalized Income,-17940000.0
NURECA.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-17940000.0
NURECA.NS,income,2024-03-31 00:00:00,Total Expenses,1044970000.0
NURECA.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,8490000.0
NURECA.NS,income,2024-03-31 00:00:00,Diluted Average Shares,10022346.0
NURECA.NS,income,2024-03-31 00:00:00,Basic Average Shares,10022346.0
NURECA.NS,income,2024-03-31 00:00:00,Diluted EPS,-1.79
NURECA.NS,income,2024-03-31 00:00:00,Basic EPS,-1.79
NURECA.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,-17940000.0
NURECA.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,-17940000.0
NURECA.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
NURECA.NS,income,2024-03-31 00:00:00,Net Income,-17940000.0
NURECA.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,-17940000.0
NURECA.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,-17940000.0
NURECA.NS,income,2024-03-31 00:00:00,Tax Provision,-7500000.0
NURECA.NS,income,2024-03-31 00:00:00,Pretax Income,-25440000.0
NURECA.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,105140000.0
NURECA.NS,income,2024-03-31 00:00:00,Special Income Charges,-4650000.0
NURECA.NS,income,2024-03-31 00:00:00,Write Off,4650000.0
NURECA.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-4890000.0
NURECA.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,1710000.0
NURECA.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,4890000.0
NURECA.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,38920000.0
NURECA.NS,income,2024-03-31 00:00:00,Operating Income,-125690000.0
NURECA.NS,income,2024-03-31 00:00:00,Operating Expense,438820000.0
NURECA.NS,income,2024-03-31 00:00:00,Other Operating Expenses,293190000.0
NURECA.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,23620000.0
NURECA.NS,income,2024-03-31 00:00:00,Amortization,3160000.0
NURECA.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,23620000.0
NURECA.NS,income,2024-03-31 00:00:00,Selling General And Administration,124030000.0
NURECA.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,101930000.0
NURECA.NS,income,2024-03-31 00:00:00,General And Administrative Expense,22100000.0
NURECA.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,8490000.0
NURECA.NS,income,2024-03-31 00:00:00,Gross Profit,313130000.0
NURECA.NS,income,2024-03-31 00:00:00,Cost Of Revenue,606150000.0
NURECA.NS,income,2024-03-31 00:00:00,Total Revenue,919280000.0
NURECA.NS,income,2024-03-31 00:00:00,Operating Revenue,919280000.0
NURECA.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,5078186.557438
NURECA.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.231987
NURECA.NS,income,2023-03-31 00:00:00,Normalized EBITDA,-102070000.0
NURECA.NS,income,2023-03-31 00:00:00,Total Unusual Items,21890000.0
NURECA.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,21890000.0
NURECA.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-82500000.0
NURECA.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,23880000.0
NURECA.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,755310000.0
NURECA.NS,income,2023-03-31 00:00:00,EBITDA,-80180000.0
NURECA.NS,income,2023-03-31 00:00:00,EBIT,-104060000.0
NURECA.NS,income,2023-03-31 00:00:00,Net Interest Income,37710000.0
NURECA.NS,income,2023-03-31 00:00:00,Interest Expense,3360000.0
NURECA.NS,income,2023-03-31 00:00:00,Interest Income,42210000.0
NURECA.NS,income,2023-03-31 00:00:00,Normalized Income,-99311813.442562
NURECA.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-82500000.0
NURECA.NS,income,2023-03-31 00:00:00,Total Expenses,1284650000.0
NURECA.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,10240000.0
NURECA.NS,income,2023-03-31 00:00:00,Diluted Average Shares,10000175.0
NURECA.NS,income,2023-03-31 00:00:00,Basic Average Shares,10000175.0
NURECA.NS,income,2023-03-31 00:00:00,Diluted EPS,-8.25
NURECA.NS,income,2023-03-31 00:00:00,Basic EPS,-8.25
NURECA.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,-82500000.0
NURECA.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,-82500000.0
NURECA.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
NURECA.NS,income,2023-03-31 00:00:00,Net Income,-82500000.0
NURECA.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,-82500000.0
NURECA.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,-82500000.0
NURECA.NS,income,2023-03-31 00:00:00,Tax Provision,-24920000.0
NURECA.NS,income,2023-03-31 00:00:00,Pretax Income,-107420000.0
NURECA.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,2570000.0
NURECA.NS,income,2023-03-31 00:00:00,Special Income Charges,-2550000.0
NURECA.NS,income,2023-03-31 00:00:00,Write Off,2550000.0
NURECA.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,37710000.0
NURECA.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,1140000.0
NURECA.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,3360000.0
NURECA.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,42210000.0
NURECA.NS,income,2023-03-31 00:00:00,Operating Income,-171420000.0
NURECA.NS,income,2023-03-31 00:00:00,Operating Expense,529340000.0
NURECA.NS,income,2023-03-31 00:00:00,Other Operating Expenses,188750000.0
NURECA.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,23880000.0
NURECA.NS,income,2023-03-31 00:00:00,Amortization,2930000.0
NURECA.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,20950000.0
NURECA.NS,income,2023-03-31 00:00:00,Selling General And Administration,145880000.0
NURECA.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,111590000.0
NURECA.NS,income,2023-03-31 00:00:00,General And Administrative Expense,34290000.0
NURECA.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,10240000.0
NURECA.NS,income,2023-03-31 00:00:00,Gross Profit,357920000.0
NURECA.NS,income,2023-03-31 00:00:00,Cost Of Revenue,755310000.0
NURECA.NS,income,2023-03-31 00:00:00,Total Revenue,1113230000.0
NURECA.NS,income,2023-03-31 00:00:00,Operating Revenue,1113230000.0
NURECA.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,-333655.892819
NURECA.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.262721
NURECA.NS,income,2022-03-31 00:00:00,Normalized EBITDA,630260000.0
NURECA.NS,income,2022-03-31 00:00:00,Total Unusual Items,-1270000.0
NURECA.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-1270000.0
NURECA.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,449600000.0
NURECA.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,14820000.0
NURECA.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,1326240000.0
NURECA.NS,income,2022-03-31 00:00:00,EBITDA,628990000.0
NURECA.NS,income,2022-03-31 00:00:00,EBIT,614170000.0
NURECA.NS,income,2022-03-31 00:00:00,Net Interest Income,44990000.0
NURECA.NS,income,2022-03-31 00:00:00,Interest Expense,4360000.0
NURECA.NS,income,2022-03-31 00:00:00,Interest Income,52400000.0
NURECA.NS,income,2022-03-31 00:00:00,Normalized Income,450536344.107181
NURECA.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,449600000.0
NURECA.NS,income,2022-03-31 00:00:00,Total Expenses,2007430000.0
NURECA.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,6410000.0
NURECA.NS,income,2022-03-31 00:00:00,Diluted Average Shares,10000175.0
NURECA.NS,income,2022-03-31 00:00:00,Basic Average Shares,10000175.0
NURECA.NS,income,2022-03-31 00:00:00,Diluted EPS,44.96
NURECA.NS,income,2022-03-31 00:00:00,Basic EPS,44.96
NURECA.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,449600000.0
NURECA.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,449600000.0
NURECA.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
NURECA.NS,income,2022-03-31 00:00:00,Net Income,449600000.0
NURECA.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,449600000.0
NURECA.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,449600000.0
NURECA.NS,income,2022-03-31 00:00:00,Tax Provision,160210000.0
NURECA.NS,income,2022-03-31 00:00:00,Pretax Income,609810000.0
NURECA.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,2520000.0
NURECA.NS,income,2022-03-31 00:00:00,Special Income Charges,-7780000.0
NURECA.NS,income,2022-03-31 00:00:00,Write Off,7780000.0
NURECA.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,44990000.0
NURECA.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,3050000.0
NURECA.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,4360000.0
NURECA.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,52400000.0
NURECA.NS,income,2022-03-31 00:00:00,Operating Income,548050000.0
NURECA.NS,income,2022-03-31 00:00:00,Operating Expense,681190000.0
NURECA.NS,income,2022-03-31 00:00:00,Other Operating Expenses,289610000.0
NURECA.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,14820000.0
NURECA.NS,income,2022-03-31 00:00:00,Amortization,820000.0
NURECA.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,14000000.0
NURECA.NS,income,2022-03-31 00:00:00,Selling General And Administration,271210000.0
NURECA.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,219050000.0
NURECA.NS,income,2022-03-31 00:00:00,General And Administrative Expense,52160000.0
NURECA.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,6410000.0
NURECA.NS,income,2022-03-31 00:00:00,Gross Profit,1229240000.0
NURECA.NS,income,2022-03-31 00:00:00,Cost Of Revenue,1326240000.0
NURECA.NS,income,2022-03-31 00:00:00,Total Revenue,2555480000.0
NURECA.NS,income,2022-03-31 00:00:00,Operating Revenue,2555480000.0
NURECA.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
NURECA.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
NURECA.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
NURECA.NS,income,2021-03-31 00:00:00,Total Unusual Items,-10930000.0
NURECA.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-10930000.0
NURECA.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
NURECA.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
NURECA.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
NURECA.NS,income,2021-03-31 00:00:00,EBITDA,
NURECA.NS,income,2021-03-31 00:00:00,EBIT,
NURECA.NS,income,2021-03-31 00:00:00,Net Interest Income,
NURECA.NS,income,2021-03-31 00:00:00,Interest Expense,
NURECA.NS,income,2021-03-31 00:00:00,Interest Income,17570000.0
NURECA.NS,income,2021-03-31 00:00:00,Normalized Income,
NURECA.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
NURECA.NS,income,2021-03-31 00:00:00,Total Expenses,
NURECA.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,2160000.0
NURECA.NS,income,2021-03-31 00:00:00,Diluted Average Shares,7475360.0
NURECA.NS,income,2021-03-31 00:00:00,Basic Average Shares,7475360.0
NURECA.NS,income,2021-03-31 00:00:00,Diluted EPS,62.04
NURECA.NS,income,2021-03-31 00:00:00,Basic EPS,62.04
NURECA.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
NURECA.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
NURECA.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
NURECA.NS,income,2021-03-31 00:00:00,Net Income,
NURECA.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
NURECA.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
NURECA.NS,income,2021-03-31 00:00:00,Tax Provision,
NURECA.NS,income,2021-03-31 00:00:00,Pretax Income,
NURECA.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
NURECA.NS,income,2021-03-31 00:00:00,Special Income Charges,-10930000.0
NURECA.NS,income,2021-03-31 00:00:00,Write Off,10930000.0
NURECA.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
NURECA.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,1250000.0
NURECA.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
NURECA.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,17570000.0
NURECA.NS,income,2021-03-31 00:00:00,Operating Income,
NURECA.NS,income,2021-03-31 00:00:00,Operating Expense,
NURECA.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
NURECA.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
NURECA.NS,income,2021-03-31 00:00:00,Amortization,0.0
NURECA.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
NURECA.NS,income,2021-03-31 00:00:00,Selling General And Administration,165840000.0
NURECA.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,157260000.0
NURECA.NS,income,2021-03-31 00:00:00,General And Administrative Expense,8580000.0
NURECA.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,2160000.0
NURECA.NS,income,2021-03-31 00:00:00,Gross Profit,
NURECA.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
NURECA.NS,income,2021-03-31 00:00:00,Total Revenue,
NURECA.NS,income,2021-03-31 00:00:00,Operating Revenue,
